Investor Relations

Investor Relations

Myriad Pharmaceuticals, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing novel small molecule drugs that address severe medical conditions, including cancer and HIV infection. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.

Recent Releases

Feb 16, 2010
Myriad Pharmaceuticals Reports Second Quarter FY' 2010 Financial Results

Feb 3, 2010
Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th

View all releases »

Events & Presentations

Apr 17, 2010
AACR 101st Annual Meeting

Jun 4, 2010
ASCO Annual Meeting

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
Myriad Pharmaceuticals, Inc.
Price: 4.79
Change: 0.11
Day High: 4.79
Day Low: 4.66
Volume: 113,200
Delayed at least 20 minutes.
Provided by eSignal.